Bioorganic and Medicinal Chemistry Letters p. 1531 - 1536 (1998)
Update date:2022-08-04
Topics: Selectivity Clinical Trials Lead Optimization Regulatory Approval Toxicity and Safety Assessment Toxicity and Safety Formulation Functional Group Introduction Lipophilicity and Solubility Metabolic Stability Bioisosteric Replacement
Van Maarseveen, Jan H.
Den Hartog, Jack A.J.
Tipker, Koos
Reinders, Jan-Hendrik
Brakkee, Joost
Schoen, Uwe
Kehrbach, Wolfgang
Kruse, Chris G.
The design and synthesis of an orally active LMW non-peptide GPIIb/IIIa antagonist, based on a N,N'-bisphenylpiperazine scaffold, is described. The optimal compound showed a high in vitro binding potency (pIC50=8.7) in combination with potent oral antithrombotic activity (30-40% inhibition of thrombus growth at 0.3-3 mg/kg) with a duration of action of >90 min. in a hamster cheek pouch model.
View MoreChangzhou Hopschain Chemical Co.,Ltd
website:http://www.hopschem.cn/products.html
Contact:86-519-85528066
Address:Room 710, Unit A, Xingbei Development Mansion, Tongjiang Road, Changzhou City,213000, China
TIANJIN ZHONGXIN CHEMTECH CO.,LTD.
Contact:86-022-66880623
Address:FINANCIAL STREET WEST BLK 7, #308, NO.52 XINCHENG WEST ROAD, TEDA, TIANJIN, P.R.CHINA
Changsha Yonta Industry Co., Ltd.
Contact:+ 86-731-8535 2228
Address:Rm.1717, North Bldg., No.368, East 2nd Ring Road(2nd Section)
Jiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110132
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
Contact:886 2 2541 0022
Address:8 Fl., No. 11, Sec. 1, Chung Shan North Rd., Taipei, Taiwan R.O.C.
Doi:10.1021/ja711120r
(2008)Doi:10.1002/1099-0690(200107)2001:13<2535::AID-EJOC2535>3.0.CO;2-V
(2001)Doi:10.1039/b101312m
(2001)Doi:10.1021/jm00268a004
(1973)Doi:10.1021/jo00235a005
(1987)Doi:10.1021/acs.orglett.0c02294
(2020)
